Schweizerischer Nationalfonds / Fonds national suisse
Agency photos aestheticise dying
plus
Actualités sur Medizin, Gesundheit
Huma collaborates with Google Cloud to improve healthcare through generative AI
New York (ots/PRNewswire) - - Huma aims to further support patients and the healthcare workforce by enhancing its regulated Software as Medical Device (SaMD) platform with the addition of generative AI applications - Huma is leveraging Google Cloud's Vertex AI platform and exploring the use of other Google GenAI tools such as Med-PaLM 2 - Huma and Google Cloud are ...
plusHearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Tübingen, Germany (ots) - Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 — during four presentations at industry and research meetings from August 29 to September 5. From August 29–31, Acousia ...
plusSuccessful FDA inspection at Aurisco's manufacturing site in Yangzhou, China
Yangzhou, China (ots/PRNewswire) - Aurisco Pharmaceutical today announced that its cGMP manufacturing plant in Yangzhou has successfully passed a USFDA inspection. Aurisco Pharmaceutical announced today that its API and FDF plant in Yangzhou, China has successfully passed a cGMP inspection by the US Food and Drug Administration (USFDA). The inspection, carried out by ...
plusGrünenthal and Kyowa Kirin International Announce Successful Completion of Deal to Enter Joint Venture Collaboration
Aachen, Germany and Tokyo, Japan (ots) - - The Joint Venture Collaboration includes a portfolio of 13 brands across six therapeutic areas, with the majority of revenue resulting from pain management medicines - The new enterprise will be branded as Grünenthal Meds. Grünenthal owns a 51 percent majority share and ...
plusCartiHeal Announces First Commercial Implantation of Agili-C™ in the US
Kfar Saba, Israel (ots/PRNewswire) - CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects in arthritic and non-arthritic knee-joints, today announced its first commercial implantation of Agili-C in the US by Dr. Ken Zaslav, a specialist in Orthopedic Surgery and Sports Medicine at Northwell Health in New York City, NY. The ...
plusPRODUCTLIFE GROUP ACQUIRES RNI, EXPANDING ITS SCIENTIFIC AND REGULATORY OFFERING TO SELFCARE PRODUCTS
Paris (ots/PRNewswire) - ProductLife Group, a global provider of regulatory and compliance services for the life sciences industry, strengthens its regulatory expertise in borderline products with the acquisition of RNI, a consulting firm providing global regulatory and scientific services across the entire spectrum ...
plusK-Businesscom AG Switzerland announces strategic partnership with Anapaya amidst ongoing expansion
plusSchweizerischer Nationalfonds / Fonds national suisse
The insatiable virus hunter
plusUkraine: At least three children killed or injured on average daily in 500 days of war
Ukraine: At least three children killed or injured on average daily in 500 days of war Zurich/Kyiv, 6 July 2023 – An average of three children have been killed or injured every day in Ukraine since the escalation of the war nearly 500 days ago, Save the Children said today, with many more left so distressed they are struggling to sleep or speak. From 24 February ...
plusDRC REMAINS EPICENTRE OF CHILD SUFFERING IN WAR AS COUNTRY TOPS WORLD LIST OF GRAVE VIOLATIONS AGAINST CHILDREN
DRC REMAINS EPICENTRE OF CHILD SUFFERING IN WAR AS COUNTRY TOPS WORLD LIST OF GRAVE VIOLATIONS AGAINST CHILDREN Zurich/Kinshasa, 27 June 2023 – The Democratic Republic of Congo (DRC) had the highest number of grave violations against children in armed conflict in the world for a second year in a row in 2022, with ...
plusArtilysin® - A Groundbreaking "Green Pharma" Solution
plusD&A Pharma : Despite the latest alarming figures on alcohol dependence, France is delaying the use of sodium oxybate, which has been prescribed for almost 30 years in Italy and Austria
Paris (ots/PRNewswire) - At the beginning of June, the health authorities hammered it home once again: "The health, social and economic consequences of alcohol consumption represent a burden for French society." The results are alarming: every year in France, alcohol is the cause of 49,000 deaths and an estimated ...
plusREVEAL GENOMICS® ANNOUNCES POSITIVE TOP-LINE RESULTS FOR HER2DX® IN MEDSIR'S PHERGAIN TRIAL
Barcelona, Spain (ots/PRNewswire) - - HER2DX® pCR-score was significantly associated with pathological complete response in patients with HER2+ breast cancer treated with trastuzumab and pertuzumab, with or without chemotherapy. - HER2DX® risk-score identified 85% of patients with an invasive disease event as ...
plusCroma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
Vienna (ots/PRNewswire) - Croma-Pharma® ('Croma') announced today that in June the first patient will be enrolled in the clinical trial1 for the approval of its hyaluronic acid dermal filler Princess® Volume Plus Lidocaine2 in China. The randomised, multi-centre, evaluator blinded, parallel group, active ...
plusHuma receives multi-condition US FDA 510(k) Class II regulatory clearance for its configurable SaMD disease management platform
New York and London (ots/PRNewswire) - - Class II clearance expands the patient population that can be managed - Companies working with Huma's platform can now launch algorithm innovations more quickly in a compliant and de-risked manner, democratising digital health innovation across the industry - Clearance was ...
plusCroma-Pharma: Launch of topical anaesthetic Pliaglis® in Europe
Vienna (ots/PRNewswire) - Croma-Pharma, a global player and challenger in the dynamically growing, minimally invasive aesthetics market, announces that it will launch Pliaglis®, a topical local anaesthetic for superficial dermatological procedures, in its European core markets including Germany, the United Kingdom ("UK"), and Ireland. Further markets including Brazil will follow by the end of 2023. The anaesthetic cream ...
plusDEBIOPHARM SHARES ONCOLOGY PROGRAM UPDATES AT ASCO 2023 FOR NOVEL WEE1 INHIBITOR, AND FIRST-IN-CLASS CA IX THERANOSTIC APPROACH
Lausanne, Switzerland (ots) - - Debiopharm will highlight diversified approaches and commitment to improving outcomes for patients with cancer at the 2023 American Society of Clinical Oncology Conference - A poster presentation and discussion will cover promising interim results with Debio 0123, a potent, highly ...
plusAstrasana and Clever Leaves Partner to Establish International Supply Agreement For Medical Cannabis Extracts in Czech Republic and Switzerland
plusDEBIOPHARM LAUNCHES PHASE 1 RESEARCH IN SMALL CELL LUNG CANCER WITH WEE1 INHIBITOR DEBIO 0123 TO OUTSMART DDR IN SMALL CELL LUNG CANCER
Lausanne, Switzerland (ots) - - Debiopharm combines its potent WEE1-inhibitor Debio 0123 with standard-of-care therapy to short-circuit DNA damage repair (DDR) in adults with recurrent or progressive small cell lung cancer (SCLC). - The first patient dosed at Vall d’Hebron Hospital (Barcelona, Spain), was ...
plusSchweizerischer Nationalfonds / Fonds national suisse
The age of blood stains says more about the crime
Bern (ots) - The composition of blood stains changes over the course of weeks and months. Forensic medicine hopes to make use of this fact in future to convict suspects - or to prove their innocence. The blood-stained paper lay on the roof terrace for almost a year, protected from the rain but otherwise exposed to the elements. Fortunately it wasn't evidence of a violent crime; no, the drops of blood were part of a ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Mosquitoes prefer cooler temperatures
Bern (ots) - Mosquitoes have thermal preferences. This is an important parameter to better predict outbreaks of diseases transmitted by these insects. "If they have a choice, when it's hot, mosquitoes hide in a cool place to rest," says Niels Verhulst, author of a study recently published in the journal Thermal Biology (*). The entomologist from the University of Zurich summarises the results of the experiment he ...
plusHuma named for its successful and innovative approach to clinical trials in new UK government review
New York and London (ots/PRNewswire) - - Huma's innovative approach to medical research cited in Lord James O'Shaughnessy's review for clinical trials improvement in the UK - The review is part of a new widespread policy approach to ignite the UK's life sciences sector - Innovating clinical trials using digital technologies such as Huma's platforms can make them more ...
plusDeep Breath Intelligence Teams with HTEC Group and Effectum Medical to Accelerate the Launch of CE-marked device under IVDD
Belgrade, Serbia (ots/PRNewswire) - Deep Breath Intelligence (DBI), a MedTech company unleashing the huge potential of exhaled breath analysis through machine learning, has selected HTEC Group and Effectum Medical as primary innovation facilitators to help them achieve greater speed in meeting both software and ...
plusDebiopharm Partners with Genedata to Digitalize Translational Research
Basel, Switzerland (ots) - Pioneer in advancing tomorrow’s standard of care to cure cancer and infectious diseases, Debiopharm selects Genedata Profiler, an industry-leading digital platform for translational and reverse translational research, as the cornerstone of its research and development strategy. Genedata, the leading provider of enterprise software solutions ...
plusGrünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee
Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...
plusEuropean study highlights need to improve the quality of conversations about induction of labour (IoL) in clinical settings
Amsterdam (ots/PRNewswire) - - Almost 1 in 2 women (49%) felt the experience of IoL differed from their expectations - The majority of expectant mothers (65%) did not feel fully involved in choosing which method of IoL they prefer - Findings emphasize the importance of collaborative decision-making between ...
plusDEBIOPHARM LAUNCHES PHASE 1/2 COMBINATION TRIAL INVESTIGATING BRAIN-PENETRANT SELECTIVE WEE1 INHIBITOR FOR BRAIN CANCER PATIENTS
Lausanne (ots) - - Glioblastomas (GBM) are among the most aggressive and lethal tumors of the central nervous system with a 5-year survival rate of only 6.8%. - Debiopharm is combining its potent, brain penetrant WEE1 inhibitor Debio 0123 with standard of care (SOC) therapy. Debio 0123 hopes to hinder DNA damage ...
plusFDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT ON WORLD ENVIRONMENT DAY TO HIGHLIGHT SUSTAINABLE DENTAL PRACTICES FOR A GREENER FUTURE
plus/C O R R E C T I O N -- Croma-Pharma/
Vienna (ots/PRNewswire) - In the news release, Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter, issued 09-May-2023 by Croma-Pharma over PR Newswire, we are advised by the company that the footnote [1] has been updated. The complete, corrected release follows: Croma-Pharma reports 27% revenue growth in 2022 and targets further revenue growth in 2023 and thereafter - ...
plus
Précédent12345678910Suivant